Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 3
1963 2
1964 1
1966 1
1969 1
1970 5
1971 3
1972 5
1973 2
1974 4
1975 7
1976 4
1977 10
1978 6
1979 7
1980 10
1981 19
1982 12
1983 15
1984 11
1985 18
1986 27
1987 21
1988 20
1989 29
1990 44
1991 51
1992 47
1993 72
1994 81
1995 76
1996 99
1997 99
1998 112
1999 118
2000 136
2001 133
2002 176
2003 232
2004 274
2005 316
2006 362
2007 408
2008 489
2009 576
2010 709
2011 802
2012 886
2013 989
2014 1126
2015 1297
2016 1286
2017 1555
2018 1595
2019 1762
2020 2032
2021 2329
2022 2715
2023 287
Text availability
Article attribute
Article type
Publication date

Search Results

21,044 results
Results by year
Filters applied: . Clear all
Page 1
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution.
Cao Y, Jian F, Wang J, Yu Y, Song W, Yisimayi A, Wang J, An R, Chen X, Zhang N, Wang Y, Wang P, Zhao L, Sun H, Yu L, Yang S, Niu X, Xiao T, Gu Q, Shao F, Hao X, Xu Y, Jin R, Shen Z, Wang Y, Xie XS. Cao Y, et al. Among authors: yu l. Nature. 2022 Dec 19. doi: 10.1038/s41586-022-05644-7. Online ahead of print. Nature. 2022. PMID: 36535326
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial.
Butler CC, Hobbs FDR, Gbinigie OA, Rahman NM, Hayward G, Richards DB, Dorward J, Lowe DM, Standing JF, Breuer J, Khoo S, Petrou S, Hood K, Nguyen-Van-Tam JS, Patel MG, Saville BR, Marion J, Ogburn E, Allen J, Rutter H, Francis N, Thomas NPB, Evans P, Dobson M, Madden TA, Holmes J, Harris V, Png ME, Lown M, van Hecke O, Detry MA, Saunders CT, Fitzgerald M, Berry NS, Mwandigha L, Galal U, Mort S, Jani BD, Hart ND, Ahmed H, Butler D, McKenna M, Chalk J, Lavallee L, Hadley E, Cureton L, Benysek M, Andersson M, Coates M, Barrett S, Bateman C, Davies JC, Raymundo-Wood I, Ustianowski A, Carson-Stevens A, Yu LM, Little P; PANORAMIC Trial Collaborative Group. Butler CC, et al. Among authors: yu lm. Lancet. 2022 Dec 22:S0140-6736(22)02597-1. doi: 10.1016/S0140-6736(22)02597-1. Online ahead of print. Lancet. 2022. PMID: 36566761 Free PMC article.
Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation.
Shi C, Wang Y, Wu M, Chen Y, Liu F, Shen Z, Wang Y, Xie S, Shen Y, Sang L, Zhang Z, Gao Z, Yang L, Qu L, Yang Z, He X, Guo Y, Pan C, Che J, Ju H, Liu J, Cai Z, Yan Q, Yu L, Wang L, Dong X, Xu P, Shao J, Liu Y, Li X, Wang W, Zhou R, Zhou T, Lin A. Shi C, et al. Among authors: yu l. Nat Commun. 2022 Nov 14;13(1):6951. doi: 10.1038/s41467-022-34346-x. Nat Commun. 2022. PMID: 36376293 Free PMC article.
Galectin-2 in Health and Diseases.
Negedu MN, Duckworth CA, Yu LG. Negedu MN, et al. Among authors: yu lg. Int J Mol Sci. 2022 Dec 25;24(1):341. doi: 10.3390/ijms24010341. Int J Mol Sci. 2022. PMID: 36613785 Free PMC article. Review.
The star target in SLE: IL-17.
Yang Y, Yan C, Yu L, Zhang X, Shang J, Fan J, Zhang R, Ren J, Duan X. Yang Y, et al. Among authors: yu l. Inflamm Res. 2022 Dec 20. doi: 10.1007/s00011-022-01674-z. Online ahead of print. Inflamm Res. 2022. PMID: 36538077 Review.
Potential biomarkers of atopic dermatitis.
Yu L, Li L. Yu L, et al. Front Med (Lausanne). 2022 Nov 17;9:1028694. doi: 10.3389/fmed.2022.1028694. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36465933 Free PMC article. Review.
Smart data collection for CryoEM.
Bepler T, Borst AJ, Bouvette J, Cannone G, Chen S, Cheng A, Cheng A, Fan Q, Grollios F, Gupta H, Gupta M, Humphreys T, Kim PT, Kuang H, Li Y, Noble AJ, Punjani A, Rice WJ, Oscar S Sorzano C, Stagg SM, Strauss J, Yu L, Carragher B, Potter CS. Bepler T, et al. Among authors: yu l. J Struct Biol. 2022 Dec;214(4):107913. doi: 10.1016/j.jsb.2022.107913. Epub 2022 Oct 28. J Struct Biol. 2022. PMID: 36341954
Advances in pharmacokinetics and pharmacodynamics of PD-1/PD-L1 inhibitors.
Yan T, Yu L, Shangguan D, Li W, Liu N, Chen Y, Fu Y, Tang J, Liao D. Yan T, et al. Among authors: yu l. Int Immunopharmacol. 2022 Dec 30;115:109638. doi: 10.1016/j.intimp.2022.109638. Online ahead of print. Int Immunopharmacol. 2022. PMID: 36587500 Free article. Review.
21,044 results
You have reached the last available page of results. Please see the User Guide for more information.